Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q4 and FY 2024-25 scheduled to be held on May 16, 2025 at 04:00 P.M. (IST).
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has informed the stock exchanges about an earnings conference call scheduled for May 16, 2025, at 4:00 PM IST. The call is to discuss the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2025. It will be moderated by Ambit Capital, with Managing Director Swapnil Shah, Chairperson Sanjay Majmudar, and CFO Deval Shah representing the company. The audio recording and transcript will later be published on the company's website. Dial-in numbers for participants in India and internationally have been provided.
This is a routine procedural announcement and not the results themselves. It signals that the company's Q4 and FY25 audited numbers are imminent, and investors will get direct management commentary shortly after results are declared.